362 related articles for article (PubMed ID: 32933049)
1. MuRF1/TRIM63, Master Regulator of Muscle Mass.
Peris-Moreno D; Taillandier D; Polge C
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933049
[TBL] [Abstract][Full Text] [Related]
2. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
3. UBE2L3, a Partner of MuRF1/TRIM63, Is Involved in the Degradation of Myofibrillar Actin and Myosin.
Peris-Moreno D; Malige M; Claustre A; Armani A; Coudy-Gandilhon C; Deval C; Béchet D; Fafournoux P; Sandri M; Combaret L; Taillandier D; Polge C
Cells; 2021 Aug; 10(8):. PubMed ID: 34440743
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin Ligases at the Heart of Skeletal Muscle Atrophy Control.
Peris-Moreno D; Cussonneau L; Combaret L; Polge C; Taillandier D
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466753
[TBL] [Abstract][Full Text] [Related]
5. UBE2D2 is not involved in MuRF1-dependent muscle wasting during hindlimb suspension.
Polge C; Koulmann N; Claustre A; Jarzaguet M; Serrurier B; Combaret L; Béchet D; Bigard X; Attaix D; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():488-493. PubMed ID: 27378730
[TBL] [Abstract][Full Text] [Related]
6. Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy.
Eddins MJ; Marblestone JG; Suresh Kumar KG; Leach CA; Sterner DE; Mattern MR; Nicholson B
Cell Biochem Biophys; 2011 Jun; 60(1-2):113-8. PubMed ID: 21448668
[TBL] [Abstract][Full Text] [Related]
7. Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis.
Koyama S; Hata S; Witt CC; Ono Y; Lerche S; Ojima K; Chiba T; Doi N; Kitamura F; Tanaka K; Abe K; Witt SH; Rybin V; Gasch A; Franz T; Labeit S; Sorimachi H
J Mol Biol; 2008 Mar; 376(5):1224-36. PubMed ID: 18222470
[TBL] [Abstract][Full Text] [Related]
8. Regulation of nicotinic acetylcholine receptor turnover by MuRF1 connects muscle activity to endo/lysosomal and atrophy pathways.
Rudolf R; Bogomolovas J; Strack S; Choi KR; Khan MM; Wagner A; Brohm K; Hanashima A; Gasch A; Labeit D; Labeit S
Age (Dordr); 2013 Oct; 35(5):1663-74. PubMed ID: 22956146
[TBL] [Abstract][Full Text] [Related]
9. Identification of the MuRF1 Skeletal Muscle Ubiquitylome Through Quantitative Proteomics.
Baehr LM; Hughes DC; Lynch SA; Van Haver D; Maia TM; Marshall AG; Radoshevich L; Impens F; Waddell DS; Bodine SC
Function (Oxf); 2021; 2(4):zqab029. PubMed ID: 34179788
[TBL] [Abstract][Full Text] [Related]
10. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia.
Bowen TS; Adams V; Werner S; Fischer T; Vinke P; Brogger MN; Mangner N; Linke A; Sehr P; Lewis J; Labeit D; Gasch A; Labeit S
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):939-953. PubMed ID: 28887874
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1.
Willis MS; Parry TL; Brown DI; Mota RI; Huang W; Beak JY; Sola M; Zhou C; Hicks ST; Caughey MC; D'Agostino RB; Jordan J; Hundley WG; Jensen BC
Circ Heart Fail; 2019 Mar; 12(3):e005234. PubMed ID: 30871347
[TBL] [Abstract][Full Text] [Related]
13. Modulation of muscle atrophy, fatigue and MLC phosphorylation by MuRF1 as indicated by hindlimb suspension studies on MuRF1-KO mice.
Labeit S; Kohl CH; Witt CC; Labeit D; Jung J; Granzier H
J Biomed Biotechnol; 2010; 2010():693741. PubMed ID: 20625437
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive imaging of in vivo MuRF1 expression during muscle atrophy.
Li W; Claypool MD; Friera AM; McLaughlin J; Baltgalvis KA; Smith IJ; Kinoshita T; White K; Lang W; Godinez G; Payan DG; Kinsella TM
PLoS One; 2014; 9(4):e94032. PubMed ID: 24710205
[TBL] [Abstract][Full Text] [Related]
15. DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy.
Nowak M; Suenkel B; Porras P; Migotti R; Schmidt F; Kny M; Zhu X; Wanker EE; Dittmar G; Fielitz J; Sommer T
J Cell Sci; 2019 Sep; 132(17):. PubMed ID: 31391242
[TBL] [Abstract][Full Text] [Related]
16. Exercise training has beneficial anti-atrophy effects by inhibiting oxidative stress-induced MuRF1 upregulation in rats with diabetes.
Chen GQ; Mou CY; Yang YQ; Wang S; Zhao ZW
Life Sci; 2011 Jul; 89(1-2):44-9. PubMed ID: 21620866
[TBL] [Abstract][Full Text] [Related]
17. High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1).
Jaitovich A; Angulo M; Lecuona E; Dada LA; Welch LC; Cheng Y; Gusarova G; Ceco E; Liu C; Shigemura M; Barreiro E; Patterson C; Nader GA; Sznajder JI
J Biol Chem; 2015 Apr; 290(14):9183-94. PubMed ID: 25691571
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II Induces Skeletal Muscle Atrophy by Activating TFEB-Mediated MuRF1 Expression.
Du Bois P; Pablo Tortola C; Lodka D; Kny M; Schmidt F; Song K; Schmidt S; Bassel-Duby R; Olson EN; Fielitz J
Circ Res; 2015 Aug; 117(5):424-36. PubMed ID: 26137861
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury.
Aniort J; Polge C; Claustre A; Combaret L; Béchet D; Attaix D; Heng AE; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():505-516. PubMed ID: 27102410
[TBL] [Abstract][Full Text] [Related]
20. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I.
Kedar V; McDonough H; Arya R; Li HH; Rockman HA; Patterson C
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18135-40. PubMed ID: 15601779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
